Stock fact sheet · data as of
Agilent Technologies, Inc. (A): fair value, margin of safety and Wheel Score
Healthcare · Medical - Diagnostics & Research · United States · Blend
Is A undervalued?
Agilent Technologies, Inc. (A) closed at 175.55 on 16 Oct 2026, 144% above the GLS average fair value of 72.05. 9 of the 9 models that produced a number value the shares below the current price. A gap this wide usually means the market is paying for growth or a story the trailing numbers do not show yet; the models work from filed results, not forecasts, so they are conservative by design.
There is a wide gap between DDM (15.01) and Graham Growth (139.87). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files A under Blend.
Nine valuation models for A
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 67.23 | -62% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 54.77 | -69% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 139.87 | -20% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 49.82 | -72% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 33.20 | -81% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 120.99 | -31% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 110.83 | -37% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | 15.01 | -91% | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend |
| EPV | 56.74 | -68% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -4.94 | -103% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 173.08 | -1% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Agilent Technologies, Inc. scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. On durability A scores 6.7/10 on the GLS Moat - a middle reading; the Scorecard on the Quote page's Financials tab shows which ten-year lines are steady and which are not.
Returns on capital are high - ROIC 12.9%, ROE 19.3%, ROA 10.2% - with debt at 0.50 times equity and a free-cash-flow yield of 2.9%.
The dividend yield is 0.58% with a payout ratio of 20% - a small yield that leaves most of the earnings in the business. Revenue comes mainly from Agilent CrossLab 42%, Life Sciences and Applied Markets 40%, Applied Markets 18% (quarter Q3 FY2026).
Institutional ownership scores 10/10, insider activity 3/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 12.9% |
|---|---|---|---|
| GLS Moat | 6.7 / 10 | ROE | 19.3% |
| Debt / equity | 0.50 | ROA | 10.2% |
| Free-cash-flow yield | 2.9% | Payout ratio | 20% |
| Institutions | 10 / 10 | Insiders · Congress | 3 · 5 / 10 |
Wheel Score 62: Fair
A Wheel Score of 62 puts Agilent Technologies, Inc. in the Fair band - below the 70 the Sunday Scan requires. Value 0/25, Health 13/20, Moat 10/15, Premium 19/20 and Stability 20/20; the weakest part is Value (0/25).
Implied volatility is 34% on the near-the-money contracts 20-60 days out: some premium, but under the 35-60% range the Wheel Score pays full marks for (19 of 20 points). Chain open interest is 33,887 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 1.9M shares a day on a market cap of $49.5B, with a beta of 1.21 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 20 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 0 / 25 | -144% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 10 / 15 | moat 6.7/10 | |
| Premium | 19 / 20 | implied volatility 34% | |
| Stability | 20 / 20 | 1.9M shares/day, $49.5B cap, beta 1.21 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 23 Nov 2026 (after the close), 38 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Diagnostics & Research
The 12 companies below are the closest to Agilent Technologies, Inc. by market cap within the Medical - Diagnostics & Research industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| IQV IQVIA Holdings Inc. | 271.04 | 193.82 | -40% | 65Good | $44.6B |
| IDXX IDEXX Laboratories, Inc. | 547.18 | 377.99 | -45% | 70Good | $43.1B |
| WAT Waters Corporation | 436.91 | 85.55 | -411% | 57Fair | $42.9B |
| NTRA Natera, Inc. | 404.79 | 8.14 | -4874% | 45Weak | $58.3B |
| ILMN Illumina, Inc. | 267.93 | 113.15 | -137% | 58Fair | $40.5B |
| MTD Mettler-Toledo International Inc. | 1,639.04 | 647.54 | -153% | 60Fair | $32.8B |
| DGX Quest Diagnostics Incorporated | 239.01 | 149.02 | -60% | 58Fair | $26.4B |
| LH Labcorp Holdings Inc. | 325.07 | 187.71 | -73% | 56Fair | $26.4B |
| GH Guardant Health, Inc. | 165.88 | - | - | 45Weak | $22.3B |
| MEDP Medpace Holdings, Inc. | 628.60 | 504.82 | -25% | 65Good | $17.5B |
| RVTY Revvity, Inc. | 152.17 | 53.29 | -186% | 62Fair | $17.0B |
| DHR Danaher Corporation | 231.50 | 103.75 | -123% | 61Fair | $162.7B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about A
Is A undervalued right now?
No: at 175.55 the stock trades 144% above the GLS average fair value of 72.05 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.
What is the Wheel Score of A and what does it mean?
A scores 62 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for A?
72.05 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Agilent Technologies, Inc. report earnings next?
The next earnings report is due on 23 Nov 2026 (after the close), 38 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does A have listed options, and how liquid are they?
Yes. The nightly snapshot found 690 listed contracts with 33,887 open interest across all expiries and implied volatility of 34% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.